Dendritic Cell Culture: A Simple Closed Culture System Using Ficoll, Monocytes, and a Table-Top Centrifuge

Journal of Hematotherapy and Stem Cell Research

Volumn 12, Issue 5, 2003, Pages 575-585

  Celluzzi, Christina M ^a   Welbon, Craig ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; B7 ANTIGEN; CD14 ANTIGEN; CD163 ANTIGEN; CD3 ANTIGEN; CD83 ANTIGEN; CD86 ANTIGEN; FICOLL; INTERLEUKIN 12; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T6 ANTIGEN; TETANUS TOXOID; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTING CELL; APHERESIS; ARTICLE; BLOOD BANK; CELL ACTIVATION; CELL ADHESION; CELL COUNT; CELL CULTURE; CELL DIFFERENTIATION; CELL FUNCTION; CELL MATURATION; CELL STRUCTURE; CELL VIABILITY; CENTRIFUGE; CONTAMINATION; CONTROLLED STUDY; CULTURE MEDIUM; DENDRITIC CELL; DENSITY GRADIENT CENTRIFUGATION; ECONOMIC ASPECT; EQUIPMENT; ERYTHROCYTE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; MONOCYTE; MONONUCLEAR CELL; NORMAL HUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ASSAY; STEM CELL; T LYMPHOCYTE; TABLE TOP CENTRIFUGE; THROMBOCYTE; WORKING TIME;

ANNEXINS; ANTIGEN PRESENTATION; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, SURFACE; APOPTOSIS; BLOOD COMPONENT REMOVAL; CELL ADHESION; CELL COUNT; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL SURVIVAL; CENTRIFUGATION; CYTOKINES; DENDRITIC CELLS; FICOLL; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERFERON TYPE II; INTERLEUKIN-4; INTERLEUKINS; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; LYMPHOCYTE ACTIVATION; MONOCYTES; PHYTOHEMAGGLUTININS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0142152437     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581603322448286     Document Type: Article

References (22)

1. Tjoa BA, SJ Simmons, VA Bowes, H Ragde, M Rogers, A Elgamel, GM Kenney, OE Cobb, RC Ireton, MJ Troyjak, AL Salgaller, AL Boynton and GP Murphy. (1998). Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PMSA peptides. The Prostate 36:39-44.
2. Nestle FO, S Alijagic, M Gilliet, Y Sun, S Grabbe, R Dummer, G Burg and D Schadendorf. (1998). Vaccination of melanoma patients with peptide- or tumor lysate- pulsed dendritic cells. Nature Med 4:328-332.
3. Banchereau J. (1997). Dendritic cells: therapeutic potentials. Tranfus Sci 18:313-326.
4. Zheng F, XL Huang, L. Zheng, C Wilson, L Borowski, J Liebmann, P Gupta, J Margolick and C Rinaldo. (1997). Cultured dendritic cells retain HIV-1 antigen-presenting cavity for memory CTL during progressive HIV-1 infection. J Immunol 159:4973-4982.
5. Austyn JM. (2000). Antigen-presenting cells. Experimental and clinical studies of dendritic cells. Am J Respir Crit Care Med 162:S146-S150.
6. Celluzzi CM, JI Mayordomo, WJ Storkus, MT Lotze and LD Falo, Jr. (1996). Peptide-pulsed dendritic cells induce antigen-specific, CTL-mediated protective tumor immunity. J Exp Med 183:283-287.
7. Celluzzi CM and LD Falo, Jr. (1998). Cutting Edge: Physical interaction between dendritic cells and tumor cells results in an immunogen that induces protecfive and therapeutic tumor rejection. J Immunol 160:3081-3085.
8. Gong J, D Chen, M Kashiwaba and D Kufe. (1997). Induction of antitumor activity by immunization with fusions of dendritic cells and carcinoma cells. Nature Med 3:558-561.
9. Banchereau J and RM Steinman. (1998). Dendritic cells and the control of immunity. Nature 392:245-252.
10. Caux C, Lebecque S, Liu Y-J, and Banchereau J. (1999). Developmental pathways of human myeloid dendritic cells. In: Dendritic Cells Biology and Clinical Applications. MT Lotze and AW Thomson, eds. Academic Press, San Diego, pp 63-92.
11. + CTLs from naive precursors. J Immunol 153:996-1003.
12. Mehta-Damani A, S Markowicz and EG Engleman. (1995). Generation of antigen-specific CD4+ T cell lines from naive precursors. Eur J Immunol 25:1206-1211.
13. Romani N, D Reider, M Heuer, S Ebner, E Kampgen, B Eibl, D Niederwieser and G Schuler. (1996). Generation of mature dendritic cells from human blood. An improved method with special regard to clinical applicability. J Immunol Methods 196:137-151.
14. Sallusto F and A Lanzavecchia. (1994). Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118.
15. Bender A, M Sapp, G Schuler, RM Steinman and N Bhardwaj. (1996). Improved methods for the generation of dendritic cells from nonproliferating progenitors in human blood. J Immunol Methods 196:121-135.
16. Pullarkat V, R Lau, SM Lee, JG Bender and JS Weber. (2002). Large-scale monocyte enrichment coupled with a closed culture system for the generation of human dendritic cells. J Immunol Methods 267:173-183.
17. Wong EC, SM Lee, K Hines, J Lee, CS Carter, W Kopp, J Bender, and EJ Read. (2002). Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers. Cytotherapy 4:65-76.
18. Wong EC, VE Maher, K Hines, J Lee, CS Carter, T Goletz, W Kopp, CL Mackall, J Berzofsky and EJ Read. (2001). Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy. Cytotherapy 3:19-29.
19. Moldenhauer A, MM Nociari, S Dias, P Lalezari, and MA Moore. (2003). Optimized culture conditions for the generation of dendritic cells from peripheral blood monocytes. Vox Sang 84:228-236.
20. Lehner M and W Holter. (2002). Endotoxin-free purification of monocytes for dendritic cell generation via discontinuous density gradient centrifugation based on diluted Ficoll-Paque Plus. Int Arch Allergy Immunol 128:73-76.
21. Karp CL, M Wysocka, X Ma, M Marovich, RE Factor, T Nutman, M Armant, L Wahl, P Cuomo and G Trinchieri. (1998). Potent suppression of IL-12 production from monocytes and dendritic cells during endotoxin tolerance. Eur J Immunol 28:3128-3136.
22. Celluzzi CM and C Welbon. (2003). A simple cryopreservation method for dendritic cells and cells used in their derivation and functional assessment. Transfusion 43:488-494.